Pereira, I.O.A.; da Silva, G.N.; Almeida, T.C.; Lima, A.P.B.; Sávio, A.L.V.; Leite, K.R.M.; Salvadori, D.M.F.
LncRNA JHDM1D-AS1 Is a Key Biomarker for Progression and Modulation of Gemcitabine Sensitivity in Bladder Cancer Cells. Molecules 2023, 28, 2412.
https://doi.org/10.3390/molecules28052412
AMA Style
Pereira IOA, da Silva GN, Almeida TC, Lima APB, Sávio ALV, Leite KRM, Salvadori DMF.
LncRNA JHDM1D-AS1 Is a Key Biomarker for Progression and Modulation of Gemcitabine Sensitivity in Bladder Cancer Cells. Molecules. 2023; 28(5):2412.
https://doi.org/10.3390/molecules28052412
Chicago/Turabian Style
Pereira, Isadora Oliveira Ansaloni, Glenda Nicioli da Silva, Tamires Cunha Almeida, Ana Paula Braga Lima, André Luiz Ventura Sávio, Katia Ramos Moreira Leite, and Daisy Maria Fávero Salvadori.
2023. "LncRNA JHDM1D-AS1 Is a Key Biomarker for Progression and Modulation of Gemcitabine Sensitivity in Bladder Cancer Cells" Molecules 28, no. 5: 2412.
https://doi.org/10.3390/molecules28052412
APA Style
Pereira, I. O. A., da Silva, G. N., Almeida, T. C., Lima, A. P. B., Sávio, A. L. V., Leite, K. R. M., & Salvadori, D. M. F.
(2023). LncRNA JHDM1D-AS1 Is a Key Biomarker for Progression and Modulation of Gemcitabine Sensitivity in Bladder Cancer Cells. Molecules, 28(5), 2412.
https://doi.org/10.3390/molecules28052412